Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone
Scleromyxedema is a rare and distinctive variant of cutaneous mucinoses of unknown etiology. It is presenting with generalized papular eruption and sclerodermoid induration. Numerous treatment modalities have been reported to produce partial or permanent responses. This study reports on a case of sc...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2016-11-01
|
Series: | Case Reports in Dermatology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/452319 |
_version_ | 1819156606594580480 |
---|---|
author | Sara Saniee Ghazaleh Davarnia |
author_facet | Sara Saniee Ghazaleh Davarnia |
author_sort | Sara Saniee |
collection | DOAJ |
description | Scleromyxedema is a rare and distinctive variant of cutaneous mucinoses of unknown etiology. It is presenting with generalized papular eruption and sclerodermoid induration. Numerous treatment modalities have been reported to produce partial or permanent responses. This study reports on a case of scleromyxedema without paraproteinemia in a subject who experienced a partial response to thalidomide and prednisolone. |
first_indexed | 2024-12-22T15:55:33Z |
format | Article |
id | doaj.art-8a72f3737c4b46de92ffebe159867a71 |
institution | Directory Open Access Journal |
issn | 1662-6567 |
language | English |
last_indexed | 2024-12-22T15:55:33Z |
publishDate | 2016-11-01 |
publisher | Karger Publishers |
record_format | Article |
series | Case Reports in Dermatology |
spelling | doaj.art-8a72f3737c4b46de92ffebe159867a712022-12-21T18:20:48ZengKarger PublishersCase Reports in Dermatology1662-65672016-11-018332733210.1159/000452319452319Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and PrednisoloneSara SanieeGhazaleh DavarniaScleromyxedema is a rare and distinctive variant of cutaneous mucinoses of unknown etiology. It is presenting with generalized papular eruption and sclerodermoid induration. Numerous treatment modalities have been reported to produce partial or permanent responses. This study reports on a case of scleromyxedema without paraproteinemia in a subject who experienced a partial response to thalidomide and prednisolone.http://www.karger.com/Article/FullText/452319ScleromyxedemaParaproteinemiaMucinosesThalidomide |
spellingShingle | Sara Saniee Ghazaleh Davarnia Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone Case Reports in Dermatology Scleromyxedema Paraproteinemia Mucinoses Thalidomide |
title | Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone |
title_full | Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone |
title_fullStr | Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone |
title_full_unstemmed | Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone |
title_short | Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone |
title_sort | scleromyxedema without paraproteinemia treatment with thalidomide and prednisolone |
topic | Scleromyxedema Paraproteinemia Mucinoses Thalidomide |
url | http://www.karger.com/Article/FullText/452319 |
work_keys_str_mv | AT sarasaniee scleromyxedemawithoutparaproteinemiatreatmentwiththalidomideandprednisolone AT ghazalehdavarnia scleromyxedemawithoutparaproteinemiatreatmentwiththalidomideandprednisolone |